- Home
- QVCGA vs COEP Comparison
QVCGA vs COEP Comparison
Compare QVCGA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- COEP
- Stock Information
- Founded
- QVCGA 1991
- COEP 2017
- Country
- QVCGA United States
- COEP United States
- Employees
- QVCGA N/A
- COEP N/A
- Industry
- QVCGA
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QVCGA
- COEP Health Care
- Exchange
- QVCGA NYSE
- COEP Nasdaq
- Market Cap
- QVCGA 26.1M
- COEP 27.4M
- IPO Year
- QVCGA N/A
- COEP N/A
- Fundamental
- Price
- QVCGA $2.64
- COEP $9.85
- Analyst Decision
- QVCGA
- COEP
- Analyst Count
- QVCGA 0
- COEP 0
- Target Price
- QVCGA N/A
- COEP N/A
- AVG Volume (30 Days)
- QVCGA 104.1K
- COEP 39.2K
- Earning Date
- QVCGA 08-07-2025
- COEP 08-15-2025
- Dividend Yield
- QVCGA N/A
- COEP N/A
- EPS Growth
- QVCGA N/A
- COEP N/A
- EPS
- QVCGA N/A
- COEP N/A
- Revenue
- QVCGA $9,800,000,000.00
- COEP $62,874.00
- Revenue This Year
- QVCGA $2.89
- COEP N/A
- Revenue Next Year
- QVCGA $0.45
- COEP N/A
- P/E Ratio
- QVCGA N/A
- COEP N/A
- Revenue Growth
- QVCGA N/A
- COEP N/A
- 52 Week Low
- QVCGA $2.27
- COEP $2.31
- 52 Week High
- QVCGA $39.74
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- COEP 64.96
- Support Level
- QVCGA N/A
- COEP $7.25
- Resistance Level
- QVCGA N/A
- COEP $10.00
- Average True Range (ATR)
- QVCGA 0.00
- COEP 0.56
- MACD
- QVCGA 0.00
- COEP 0.29
- Stochastic Oscillator
- QVCGA 0.00
- COEP 94.62
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.